Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 解剖學暨細胞生物學科所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25682
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor尹相姝(Hsiang-Shu Yin)
dc.contributor.authorBing-Hsuan Leien
dc.contributor.author雷秉軒zh_TW
dc.date.accessioned2021-06-08T06:24:35Z-
dc.date.copyright2006-08-04
dc.date.issued2006
dc.date.submitted2006-07-28
dc.identifier.citationAltier N, Stewart J. Intra-VTA infusions of the substance P analogue, DiMe-C7, and intra-accumbens infusions of amphetamine induce analgesia in the formalin test for tonic pain. Brain Res. 1993. Nov 19;628(1-2):279-85.
Altier N ,Stewart J .Dopamine Receptor Antagonists in the Nucleus Accumbens Attenuate Analgesia Induced by Ventral Tegmental Area Substance P or Morphine and by Nucleus Accumbens
Amphetamine. The Journal of Pharmacology and Experimental Therapeutics. 1998. 285:208–215
Altier N, Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 1999;65(22):2269-87. Review
Barber RP, Vaughn JE, Roberts E. The cytoarchitecture of GABAergic neurons in rat spinal cord. Brain Res. 1982 Apr 29;238(2):305-28.
Blanchard JJ, Brown SA, Horan WP, Sherwood AR. Substance use disorders in schizophrenia: review, integration, and a proposed model. Clinical Psychology Review. 2000 Mar,20(2):207-34
Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res. 2001 Apr 15;49(1-2):171-8.
Brand P and Yancey P. Pain: the gift nobody wants. HaperCollins, 1993
Cadenhead KS, Perry W, Shafer K, Braff DL. Cognitive functions in schizotypal personality disorder. Schizophr Res. 1999 May 25;37(2):123-32.
Caine SB, Koob GF. Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food. Journal of the experimental analysis of behavior. 1994 Mar;61(2):213-21.
Camp DM, DeJonghe DK, Robinson TE. Time-dependent effects of
repeated amphetamine treatment on norepinephrine in the hypothalamus and hippocampus assessed with in vivo microdialysis. Neuropsychopharmacology. 1997 Sep;17(3):130-40.
Carlson NR. Physiology of behavior 7th.Allyn and Bacon.2001
Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1988 Sep;1(3):179-86.
Carlton SM, Westlund KN, Zhang D, Willis WD.GABA-immunoreactive terminals synapse on primate spinothalamic tract cells.J Comp Neurol. 1992 Aug 22;322(4):528-37.
Chinta SJ, Andersen JK. Dopaminergic neurons. Int J Biochem Cell Biol. 2005 May;37(5):942-6.
Connor J, Makonnen E, Rostom A. Comparison of analgesic effects of khat (Catha edulis Forsk) extract, D-amphetamine and ibuprofen in mice. J Pharm Pharmacol. 2000 Jan;52(1):107-10.
Damaj MI, Martin BR, Kuhar MJ. Antinociceptive effects of supraspinal rat cart (55-102) peptide in mice. Brain Res. 2003 Sep 5;983(1-2):233-6.
Davison GC, Neale JM, Kring AM. Abnormal Psychology. 2004.
Dayer AG, Cleaver KM, Abouantoun T, Cameron HA. New GABAergic interneurons in the adult neocortex and striatum are generated from different precursors. J Cell Biol. 2005 Jan 31;168(3):415-27.
Del Arco A, Castaneda TR, Mora F. Amphetamine releases GABA in striatum of the freely moving rat: involvement of calcium and high affinity transporter mechanisms. Neuropharmacology.1998;37 (2):199-205.
Doyle AC , Maxwell DJ. Ultrastructural analysis of noradrenergic nerve terminals in the cat lumbosacral spinal dorsal horn:a dopamine-beta-hydroxylase immunocytochemical study. Brain Res. 1991, 563(329-333)
Ellinwood EH Jr, Balster RL. Rating the behavioral effects of amphetamine. Eur J Pharmacol. 1974 Sep;28(1):35-41.
Flaum M, Schultz SK. When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry. 1996 Jun;153(6):812-5.
Franklin KB. Analgesia and Abuse Potential: An Accidental Association or a Common Substrate? Pharmacol Biochem Behav. 1998.59, No. 4, pp. 993–1002
Freedman R. Schizophrenia. The New England journal of medicine. 2003 Oct 30;349(18):1738-49.
Fritschy JM and Grzanna R. Demonstration of two Separate Descending Noradrenergic Pathway to the Rat Spinal Cord : Evidence for an Intragriseal Trajectory of Locus Coerulrue Axons in Superficial Layers of Dorsal Horn. The Journal of Comparative Neurology. 1990. 291:553-582
Hammond DL. J.J. Bonica Lecture--2001: role of spinal GABA in acute and persistent nociception. Regional anesthesia and pain medicine. 2001 Nov-Dec;26(6):551-7.
Hooley JM, Delgado ML. Pain insensitivity in the relatives of schizophrenia patients. Schizophr Res. 2001 Mar 1;47(2-3):265-73.
Klink R, Boksa P and Joober R. pharmacogenomics and animal models of schizophrenia. Drug development Research. 2003;60,95-103
Hutchison KE and Swift R. Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology. 1999 Apr;143(4):394-400.
Kemppainen S and Pitkanen A. Distribution of parvalbumin, calretinin, and calbindin-D(28k) immunoreactivity in the rat amygdaloid complex and colocalization with gamma-aminobutyric acid.
J Comp Neurol. 2000 Oct 23;426(3):441-67.
Kraepelin, E. Dementia Praecox and Paraphrenia. A.S.Livingstone Edinburgh Reprinted by the Classics of Psychiatry and Behavioral Sciences Library, New York, 1989.
Kudoh A, Ishihara H, Matsuki A. Current perception thresholds and postoperative pain in schizophrenic patients. Reg Anesth Pain Med. 2000 Sep-Oct;25(5):475-9.
Lieberman, Jeffrey A; Koreen, Amy R. Neurochemistry and Neuroendocrinology of Schizophrenia: A Selective Review. Schizophrenia Bulletin. 1993, 19(2), 371-429
Gilbert AK Franklin BJ. Characterization of the analgesic properties of nomifensine in rats. Pharmacology, Biochemistry and Behavior 2001. 68:783±787
Millan MJ. Descending control of pain. Prog Neurobiol. 2002 Apr;66(6):355-474. Review
Millhorn DE. Hokfelt T. Verhofstad AA. Terenius L. Individual cells in the raphe nuclei of the medulla oblongata in rat that contain immunoreactivities for both serotonin and enkephalin project to the spinal cord. Exp Brain Res. 1989;75(3):536-42.
Mohila CA, Onn SP. Increases in the density of parvalbumin-immunoreactive neurons in anterior cingulate cortex of amphetamine-withdrawn rats: evidence for corticotropin-releasing factor in sustained elevation. Cereb Cortex. 2005 Mar;15(3):262-74
Morgan MJ, Franklin KB. 6-Hydroxydopamine lesions of the ventral t egmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test. Brain Res. 1990 Jun 11;519(1-2):144-9.
Morrow TJ, Paulson PE, Danneman PJ, Casey KL. Regional changes in forebrain activation during the early and late phase of formalin nociception: analysis using cerebral blood flow in the rat. Pain. 1998 Apr;75(2-3):355-65.
Murthy BV, Narayan B, Nayagam S. Reduced perception of pain in schizophrenia: its relevance to the clinical diagnosis of compartment syndrome. Injury. 2004 Nov;35(11):1192-3.
Nadeson R and Goodchild CS. Antinociceptive role of 5-HT1A receptors in rat spinal cord. British journal of anaesthesia. 2002 May;88(5):679-84.
Nolte S, Wong D, Lachford G. Amphetamines for schizophrenia. Cochrane database of systematic reviews. 2004 Oct 18;(4)
Ohsawa M, Dun SL, Tseng LF, Chang J, Dun NJ. Decrease of hindpaw withdrawal latency by cocaine- and amphetamine-regulated transcript peptide to the mouse spinal cord. Eur J Pharmacol. 2000 Jul 7;399(2-3):165-9
Perry W, Braff DL. Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry. 1994 Mar;151(3):363-7.
Perry W, Feifel D, Minassian A, Bhattacharjie I, Braff DL. Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission. Am J Psychiatry. 2002 Aug;159(8):1375-81
Ren K, Ruda MA. A comparative study of the calcium-binding proteins calbindin-D28K, calretinin, calmodulin and parvalbumin in the rat spinal cord.Brain Res Brain Res Rev. 1994 May;19(2):163-79. Review
Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1987;1(2):133-52. Review.
Seiden LS, Sabol KE, Ricaurte GA. Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol. 1993;33:639-77. Review
Senba SH, Yoshida S, Tohyama M, Yoshiya I. Fine Structure of noradrenergic terminals and their synapse in the rat spinal cord:an Immunohistochemical study. Brain res. 1990,526(73-80)
Sharp T, Zetterstrom T, Ljungberg T, Ungerstedt U. A direct comparison
of amphetamine-induced behaviours and regional brain dopamine
release in the rat using intracerebral dialysis. Brain Res. 1987 Jan
20;401(2):322-30.
Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. 2003 Feb;165(4):359-69
Singh MK, Giles LL, Nasrallah HA. Pain insensitivity in schizophrenia: trait or state marker? J Psychiatr Pract. 2006 Mar;12(2):90-102.
Sorkin LS, McAdoo DJ, Willis WD. Raphe magnus stimulation-induced antinociception in the cat is associated with release of amino acids as well as serotonin in the lumbar dorsal horn. Brain Res. 1993 Jul 30;618(1):95-108.
Swerdlow NR, Eastvold A, Karban B, Ploum Y, Stephany N, Geyer MA, Cadenhead K, Auerbach PP. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies.
Psychopharmacology (Berl). 2002 May;161(2):189-201.
White FJ, Kalivas PW. Neuroadaptations involved in amphetamine and
cocaine addiction. Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):141-
53. Review.
Wikberg JE, Hajos M. Spinal cord alpha 2-adrenoceptors may be located postsynaptically with respect to primary sensory neurons: destruction of primary C-afferents with neonatal capsaicin does not affect the number of [3H]clonidine binding sites in mice.Neurosci Lett. 1987 Apr 23;76(1):63-8.
Willis WD, Wesrlund KN. Neuroanatomy of the Pain System and of the Pathways that Mudulate pain. 1997 Jan;14(1):2-31
Tenn CC, Fletcher PJ, Kapur S. Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophrenia research. 2003 Nov 15;64(2-3):103-14.
Tenn CC . Kapur S. Fletcher PJ. Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition
Psychopharmacology .2005. 180: 366–376
Yee BK, Keist R, von Boehmer L, Studer R, Benke D, Hagenbuch N, Dong Y, Malenka RC, Fritschy JM, Bluethmann H, Feldon J, Mohler H, Rudolph U. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17154-9
Yeomans DC, Proudfit HK. Characterization of the foot withdrawal response to noxious radiant heat in the rat. Pain. 1994,59(85-94)
Yin HS, Chen CT, Lin TY. Age- and region-dependent alterations in the GABAergic innervation in the brain of rats treated with amphetamine. Int J Neuropsychopharmacol. 2004 Mar;7(1):35-48.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25682-
dc.description.abstract疼痛雖然是一種令人感到不悅的感受,但是卻在日常生活中扮演了相當重要的保護機制。
許多成癮以及精神分裂(schizophrenia)病人對於痛覺的感受力相當遲鈍,對於肢體傷害的感受力相當低。在臨床上,長期安非他命濫用者不但會引起藥物成癮的現象,甚至會引發難以回復的精神分裂。
動物在長期處理下,會使對此藥物產生成癮與活動異常等行為。這些動物行為的異常表現和神經化學的異常相較於精神分裂的現象有相當高的相似性,所以這些動物被用來做為研究上癮行為、精神分裂以及痛覺的動物模式。過去動物研究中發現急性安非他命處理具有降低疼痛的效果,但是對於長期重複性處理是否會引起熱痛覺感受力的變化則未知。再者,此對這些痛覺遲鈍現象的中樞機制也不清楚。
在脊髓的痛覺傳導系統中,有正腎上腺素、血清素以及GABA系統作調控。所以本實驗的目的為探討小鼠在長期安非他命處理下,觀察小鼠對熱痛覺感受力的改變。並利用組織免疫染色,觀察小鼠中樞神經系統正腎上腺素(dopamine ß-hydroxylase,DBH合成腎上腺素的酵素)、血清素(serotonin)以及GAD67(glutamic acid decarboxylase67,合成GABA的酵素)、parvalbumin、calbindin-D28K以及calretinin的變化。
小鼠在每日早、晚(早上九點與下午五點)分別利用腹腔注射安非他命(5mg/kg)或生理食鹽水,連續四日(共七劑)。並在每日早上注射完後三小時,連續四日觀察小鼠對於熱痛覺的感受力。另外兩組四天中注射生理食鹽水以及安非他命,而沒受過熱痛覺處理。組別共四組。小鼠於第四日(第七劑)早上注射後約四到五小時後作灌流犧牲,製作石蠟切片並進行組織免疫染色,觀察中樞神經系統正腎上腺素、血清素以及GABA系統的變化。
我們結果發現經連續性安非他命注射到第四天(第七劑),相較於控制組,小鼠對於熱痛覺的忍受力則有明顯提升(Day 4 S:Day 4 A=8.23±0.52: 10.67±0.79)。甚至高於第一天安非他命處理的小鼠(Day1 S : Day4 A=8.544±0.82: 10.67±0.79)
免疫組織染色結果顯示,在第四天經安非他命注射的小鼠脊髓背角calretinin細胞染色數目相對於控制組提高了320%。小鼠在經生理食鹽水注射並接腳掌熱痛覺處理,脊髓背角的5-HT表現面積比生理食鹽水處理並未經熱痛覺處理的小鼠上升了617%。小鼠在重複性安非他命注射並受腳掌熱痛覺測試下,相較於生理食鹽水注射並接受腳掌熱痛覺測試小鼠,脊髓背角的5-HT表現量則下降了16.3%。
由這些資料顯示,,小鼠在長期安非他命處理下,對藥物的反應有明顯增強,而對於熱痛覺的忍受力明顯提高。這種對痛覺忍受力上升的現象。因為我們發現脊髓背角calretinin表現上升,5-HT下降,所以有可能是因為GABA系統在脊髓背角的抑制性功能升高,抑制了痛覺的傳遞。這些也許可以解釋動物或人類長期安非他命使用所引起對痛覺感受力遲鈍的現象。這種安非他命所引起的作用會嚴重影響成癮性病患日常生活品質。
zh_TW
dc.description.provenanceMade available in DSpace on 2021-06-08T06:24:35Z (GMT). No. of bitstreams: 1
ntu-95-R93446006-1.pdf: 6473801 bytes, checksum: 7147aae44cef17edcee31d929cdb18f5 (MD5)
Previous issue date: 2006
en
dc.description.tableofcontents摘要•••••••••••••••••••••••••••••••••••••1
緒論•••••••••••••••••••••••••••••••••••••3
材料與方法•••••••••••••••••••••••••••••••13
結果••••••••••••••••••••••••••••••••••••22
討論••••••••••••••••••••••••••••••••••••28
結論••••••••••••••••••••••••••••••••••••33
參考文獻••••••••••••••••••••••••••••••••34
表格與說明•••••••••••••••••••••••••••••••42
圖表與說明•••••••••••••••••••••••••••••••50
dc.language.isozh-TW
dc.subject精神分裂zh_TW
dc.subject熱痛覺zh_TW
dc.subject敏感化zh_TW
dc.subject安非他命zh_TW
dc.subjectsensitizationen
dc.subjectthermal painen
dc.subjectamphetamineen
dc.title安非他命對於小鼠熱痛覺的影響:中樞傳導物質的角色zh_TW
dc.titleEffect of Amphetamine on Thermal Pain Sensation of Mouse:
Roles of Central Neurotransmitters
en
dc.typeThesis
dc.date.schoolyear94-2
dc.description.degree碩士
dc.contributor.oralexamcommittee王家儀,呂俊宏,林淑端,黃銀河
dc.subject.keyword安非他命,熱痛覺,敏感化,精神分裂,zh_TW
dc.subject.keywordamphetamine,thermal pain,sensitization,en
dc.relation.page76
dc.rights.note未授權
dc.date.accepted2006-07-29
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept解剖學暨生物細胞學研究所zh_TW
顯示於系所單位:解剖學暨細胞生物學科所

文件中的檔案:
檔案 大小格式 
ntu-95-1.pdf
  未授權公開取用
6.32 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved